Prostate Cancer Market: How Are Novel Hormonal Therapies Reshaping...

Ajouter une nouvelle offre d'emploi Health

2026-04-14 11:12:54 -

Prostate Cancer Market: How Are Novel Hormonal Therapies Reshaping Treatment?

Next-generation androgen receptor pathway inhibitors — enzalutamide (Xtandi), apalutamide (Erleada), darolutamide (Nubeqa), and abiraterone (Zytiga/Yonsa) — have transformed metastatic prostate cancer management from basic ADT toward multi-combination hormonal intensification, with the Prostate Cancer Market reflecting ARPI intensification as the dominant commercial treatment...

0 Commentaires 0 Parts 6 Vue 0 Aperçu